Humacyte, Inc. - Common Stock, par value $0.0001 per share (HUMA)

CUSIP: 44486Q103

Q3 2022 13F Holders as of 30 Sep 2022

Holder snapshot 7 signals
Share change
-1,579,641
Put/Call ratio
95%
SEC-reported price per share
$3.26
Number of holders
68
Value change
-$5,136,200
Number of buys
28
Open additional details 1 more signal available
Number of sells
37
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
269,769,473

Security key

44486Q103

Report period

Q3 2022

Institutions

68

Top holders

10

Ownership snapshot

Top reported holders of HUMA - Humacyte, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FRESENIUS MEDICAL CARE HO...
Disclosed value leader
FRESENIUS MEDICAL CARE HO...
Comparable rows
15/15
Latest evidence
30 Jun 2022
3/4/5 13F Lead comparable stake: 6.8% Showing 1-6 of 15 holder rows.

Quick read

FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ leads the comparable SEC ownership view at 6.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FRESENIUS MEDICAL CARE HOLDINGS INC /NY/'s linked filing trail.
Comparable ownership Top 5
FRESENIUS MEDICAL CARE HOLDINGS I... 6.8%
VANGUARD GROUP INC 0.99%
BlackRock Finance, Inc. 0.89%
York Capital Management Global Ad... 0.85%
OCONNOR, A Distinct Business Unit... 0.41%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FRESENIUS MEDICAL CARE HOLDINGS INC /NY/
3/4/5
Former 10% Shareholder
6.8%
$21,792,154
18,312,735 shares
26 Aug 2021
VANGUARD GROUP INC
13F
Company
13F
0.99%
$8,584,000
2,674,005 shares
30 Jun 2022
BlackRock Finance, Inc.
13F
Company
13F
0.89%
$7,693,000
2,396,378 shares
30 Jun 2022
York Capital Management Global Advisors, LLC
13F
Company
13F
0.85%
$7,355,000
2,291,397 shares
30 Jun 2022
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
13F
0.41%
$3,531,000
1,100,000 shares
30 Jun 2022
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
0.29%
$2,497,000
777,997 shares
30 Jun 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
68
Shares
11,840,854
Rows available
68
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
75
Q3 2022 holders
68
Holder diff
-7
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 value Q3 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .